TL;DR — DNA damage outpaces repair after age 40. NAD+ fuels PARP; NRF2 upregulates detox enzymes; sleep drives repair peaks. Track 8-OHdG or γ-H2AX if available; intervene with NAD+A molecule every cell needs for energy production, DNA repair, and activating longevity genes (sirtuins). Full glossary → substrate + NRF2A protein that turns on 200+ antioxidant and detox genes when activated. Full glossary → stack + sleep — in that order after lifestyle foundation.
What this hallmark means
Each cell faces thousands of DNA lesions daily — replication errors, UV, ROS, and environmental electrophiles. Young cells clear damage through base-excision repair (BER), nucleotide-excision repair (NER), and homologous recombination.
Aging breaks the balance:
| Failure mode | What changes | What you feel |
|---|---|---|
| PARP NAD+ drain | Strand breaks consume NAD+ faster than salvage restores it | Slow recovery, brain fog after stress |
| Oxidative adducts | 8-OHdG and lipid peroxidation products accumulate | Inflammation, fatigue, "aged" skin texture |
| Repair enzyme decline | BER/NER fidelity drops | Longer illness recovery; labs drift without cause |
Genomic instability is hallmark #1 in the López-Otín framework because DNA damage is the substrate for cancer and accelerates every downstream aging process.
Hallmark 1 · Genomic instability
A primary driver — unrepaired damage mutates the epigenome, triggers senescence, and amplifies mitochondrial ROS output.
Why this matters for your protocol
TNiC prioritizes genomic defense through two parallel axes — repair capacity (NAD+) and damage prevention (NRF2/glutathione). Most "antioxidant" products skip the repair fuel entirely.
Intervention hierarchy (evidence-weighted):
- Sleep 7–9 hours — BER peaks in slow-wave sleep (Tier A mortality data)
- NAD+ restoration (NMN) — fuels PARP-mediated strand break repair
- NRF2 activation (sulforaphane + GlyNAC) — phase-II detox and ROS interception
- Sun/ toxin minimization — behavioral layer with zero cost
López-Otín et al. Cell 2023 (PMID 36599349) — genomic instability remains a core hallmark. Kumar GlyNAC trials show reduced oxidative DNA damage markers alongside GSH restoration (PMID 33783984).
Practical intervention map
| Lever | Mechanism | Evidence | TNiC resource |
|---|---|---|---|
| NMN | ↑ NAD+ → PARP repair capacity | Tier A (NAD+ human) | NMN guide |
| GlyNAC + sulforaphane | ↓ oxidative adducts; NRF2 gene battery | Tier A | NRF2 Triad |
| Sleep optimization | BER/NER peak activity | Tier A | Sleep protocol |
| UV protection | Prevents photo-damage | Tier A (epidemiology) | Lifestyle |
← Swipe for more columns →
Your 90-day genomic defense protocol
Weeks 1–4: Fix sleep timing + UV habits. Log family cancer history in hallmark notes. Baseline hs-CRP and GSH if available.
Weeks 5–12: Add NMN 250 mg AM if NAD+ low or age 50+. Layer GlyNAC if GSH below 5.0.
Weeks 13–24: Add sulforaphane leg of NRF2 triad if oxidative markers still elevated.
Decision point at week 12: GSH or subjective recovery improved → continue. Flat oxidative markers → audit compliance before dose escalation.
Which genomic defense first?
Is sleep consistently 7+ hours for 4+ weeks?
node | GSH below 5.0 OR hs-CRP above 1.0?
Start NRF2 Triad substrate leg (GlyNAC)
node | NAD+ below 80 OR age 50+ with fatigue?
Start NMN 250 mg → retest week 4
Maintain lifestyle; optional 8-OHdG test at 6 months
Fix sleep before supplements — repair enzymes are sleep-dependent
Active cancer, prior marrow transplant, or unexplained cytopenias → oncologist/hematologist before NAD+ or antioxidant stacks
Educational decision aid — a way to organize the evidence, not a prescription. Doses and timing shown are those used in studies; confirm anything you act on with a clinician or pharmacist.
What to measure
| Signal | Type | Frequency | Success looks like |
|---|---|---|---|
| GSH | Lab | Baseline, 12 wk, 24 wk | 5.0–8.5 μmol/L |
| 8-OHdG | Lab (optional) | 6–12 months | Downward trend |
| hs-CRP | Lab | 3–6 months | <1.0 mg/L |
| Sleep duration | Wearable | Daily | 7–9 hrs avg |
| Recovery after illness | Subjective | Per event | Faster return to baseline |
← Swipe for more columns →
GSH (μmol/L)
<5.0
hs-CRP (mg/L)
>1.0
Sleep avg
6.2 hrs
Subjective recovery
Slow
GSH (μmol/L)
5.0+
hs-CRP (mg/L)
<1.0
Sleep avg
7.5+ hrs
Subjective recovery
Faster
Red flags — when to pause or escalate
Stop and consult before intensifying
- Personal or strong family cancer history — supplement stacks do not replace surveillance; coordinate with oncology
- Unexplained bruising, anemia, or frequent infections — rule out marrow issues before immune-modulating protocols
- Rising oxidative markers despite perfect compliance — investigate hidden toxin exposure or occult inflammation
- Pregnancy — insufficient safety data for NAD+ and sulforaphane protocols
Synergies worth knowing
| Stack | Covers | Best for |
|---|---|---|
| NRF2 Defense Triad | Prevention + GSH pool | Elevated oxidative stressAn imbalance between reactive oxygen species (free radicals) produced by metabolism and the antioxidant systems that neutralize them. Full glossary → |
| NAD+ Mito Stack | PARP fuel + biogenesis | NAD+ depletion + fatigue |
| GlyNAC + NMN | Repair + prevention orthogonal | Full genomic defense |
Build genomic defense stack
Toggle NMN, GlyNAC, sulforaphane — watch hallmark coverage update.
Open Stack ArchitectPersonal results template
My genomic instability log
| Date | Week | Sleep (hrs) | GSH | hs-CRP | 8-OHdG | Illness recovery | Stack notes |
|---|---|---|---|---|---|---|---|
| YYYY-MM-DD | 0 | — | — | — | — | — | Baseline |
| YYYY-MM-DD | 12 | — | — | — | — | — | Primary endpoint |
| YYYY-MM-DD | 24 | — | — | — | — | — | Maintenance |
← Swipe for more columns →
Personal response criteria: - Meaningful: GSH optimal OR hs-CRP ↓30% + faster illness recovery - Plateau: Flat at week 12 → sleep audit before new compounds - Adverse: New unexplained cytopenias → stop stack, physician workup
Further reading
- López-Otín et al. Cell 2023 — Hallmarks updated framework (PMID 36599349)
- Ciccia & Elledge. Mol Cell 2010 — DNA damage response pathways
- Kumar et al. J Gerontol A 2021 — GlyNAC oxidative stress outcomes
References
- PMID 36599349
- Kumar P et al. GlyNAC supplementation improves glutathione deficiency in aging humans. J Gerontol A Biol Sci Med Sci (2021). PMID 33783984
Links open PubMed. TNiC does not sell supplements; citations support education, not medical advice.